Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

James E Wagner Cultivation Corp JWCAF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
James E. Wagner Cultivation Corp, through its subsidiary is a licensed producer of medical cannabis focusing on producing clean, consistent cannabis using an advanced and proprietary aeroponic platform named GrowthSTORM. The company's operations are based in Kitchener, Ontario.


GREY:JWCAF - Post by User

James E Wagner Cultivation Corp > ENGAGES CMA FOR NEW INVESTOR RELATIONS PROGRAM
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by RisingFalcon99on Aug 19, 2019 8:19am
47 Views
Post# 30042218

RE:ENGAGES CMA FOR NEW INVESTOR RELATIONS PROGRAM

RE:ENGAGES CMA FOR NEW INVESTOR RELATIONS PROGRAM
Great news! Get JWCs name out there and known. Its true, all this fantastic news, but share price really hasn't shown anything but a downtrend. Any comments on the cost, is this normal? And what about the stock option, is it interesting that it's at $1.15/share?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities